Tensions high as Medicare drug negotiations advance
The selected drugs include Bristol-Myers Squibb Co.’s blood thinner Eliquis, which averages $608 in annual out-of-pocket costs and is used by 3.7 million patients.
Search Roll Call
Search the Roll Call archive by keyword, date, Congress, section, or tags.